However, a study just published in a French medical journal provides new evidence that hydroxychloroquine does not appear to help the immune system clear the coronavirus from the body. The study comes on the heels of two others – one in France and one in China – that reported some benefits in the combination of hydroxychloroquine and azithromycin for COVID-19 patients who didn’t have severe symptoms of the virus. Continue reading →
As healthcare providers across the U.S. desperately attempt to treat a rapidly growing number of patients with the coronavirus, a pharmaceutical company with ties to the Trump administration has been granted exclusive status for a drug it is developing to treat the illness—a potential windfall for the company that could put the medication out of reach for many Americans.
As The Interceptreported Monday, the Food and Drug Administration granted Gilead Sciences “orphan” drug status for remdesivir, one of several drugs being tested as potential treatments for the coronavirus, officially known as COVID-19. The designation is generally reserved for drugs that treat rare illnesses affecting fewer than 200,000 Americans—but companies can be eligible if the designation, as in this case of a rapidly spreading virus, is made before a disease spreads beyond that limit. Continue reading →
Raids by federal agents in Florida suggest a policy shift that will make it more difficult for Americans to access low-cost prescription medications. (Photo: Chris Potter/ccPix.com/Flickr/cc)
The U.S. Food and Drug Administration (FDA) raided nine stores in Central Florida that assist customers with placing orders for low-cost prescription drugs from Canada and other countries, Kaiser Health Newsreported Monday, suggesting a shift away from a long-standing policy that benefited consumers but was strongly condemned by the pharmaceutical industry.
“The storefronts primarily serve seniors who prefer in-person assistance with buying medicines from Canada and other countries, rather than using an internet site,” Kaiser reports. Bill Hepscher, co-owner of six of the stores raided last month, estimates his business serves about 10,000 people a year, and that Florida has about 20 stores similar to his. His stores are located around Tampa Bay and Orlando. Continue reading →
Bernie Sanders joined two other senators in blocking Obama’s nomination for FDA chief. (Photo: Gage Skidmore/flickr/cc)
Senator Bernie Sanders put a hold on President Barack Obama’s nominee to take over the Food and Drug Administration (FDA) on Tuesday, joining with two other senators who have also objected to Dr. Robert M. Califf’s nomination, citing his ties to corporate drug manufacturers.
“Dr. Califf’s extensive ties to the pharmaceutical industry give me no reason to believe that he would make the FDA work for ordinary Americans, rather than just the CEOs of pharmaceutical companies,” Sanders said in a statement on Tuesday. “We need someone who will work to substantially lower drug prices, implement rules to safely import brand-name drugs from Canada and hold companies accountable who defraud our government.” Continue reading →
Activists rally for a constitutional amendment overturning the Citizens United Supreme Court decision on Friday, January 21, 2011 in Washington, DC. (Photo: Brendan Hoffman)
In 2015, the iron fist of power clamped down on humanity, from warfare to terrorism (I repeat myself) to surveillance, police brutality, and corporate hegemony. The environment was repeatedly decimated, the health of citizens was constantly put at risk, and the justice system and media alike were perverted to serve the interests of the powers that be.
However, while 2015 was discouraging for more reasons than most of us can count, many of the year’s most underreported stories evidence not only a widespread pattern that explicitly reveals the nature of power, but pushback from human beings worldwide on a path toward a better world. Continue reading →
Kansas Republican Rep. Mike Pompeo to reintroduce anti-consumer, anti-choice, anti-labeling, pro-GMO law
Written by Lauren McCauley, staff writer for CommonDreams, published March 25, 2015.
Calling the legislation “diabolical and deceptive,” critics of Pompeo’s bill have vowed a fight. (Photo: CT Senate Democrats/cc/flickr)
The battle over genetically modified organisms, or GMOs, reached the U.S. capital on Wednesday when news broke that Kansas Republican Rep. Mike Pompeo will reintroduce a bill that blocks states from requiring GMO labeling.
The legislation, dubbed by critics the Deny Americans the Right-to-Know or DARK Act, grants the Secretary of Health and Human Services sole authority to mandate GMO labeling and sets forth particular standards for any label that contains claims that GMOs were or were not used in the production of the food— hampering any attempts by the Food and Drug Administration to pass legislation on the federal level. Continue reading →